New research has ruled out hormone signalling as the reason why men with acute myeloid leukaemia (AML) tend to have poorer outcomes than women, even when treated with the same intensive chemotherapy – ...

We discovered the function of the thymus and made key findings on the function of the two main subsets of lymphocytes, T cells and B cells. This was the fundamental basis for modern immunology.

We will empower our students and early-career researchers to become tomorrow’s leaders in cancer research and treatment by providing the best possible education, training and careers support. The ICR ...

Our leadership teamProfessor Kristian Helin Chief Executive and President The Chief Executive is responsible to the Board of Trustees for the overall direction of the ICR’s management, research and ...

Tony McHale (pictured above) discovered he had an alteration in the BRCA2 gene at the age of 61, putting him at a much higher risk of developing prostate cancer. Shortly after, Tony joined the IMPACT ...

The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our ...

The Centre for Molecular Pathology is a collaborative initiative between The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, aiming to identify the molecular mechanisms that ...

The Institute of Cancer Research, London, is one of the world's most influential cancer research organisations, with an outstanding record of achievement.

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Cancer discovery news Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research. Visit our main news hub to read about news on new funding ...

Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

Scientists have discovered a key protein that could be targeted with a drug to treat the most common and aggressive form of pancreatic cancer. The findings, published in Nature, show that blocking the ...